Lipo-oxytocin-1

Chemical compound
Lipo-oxytocin-1
Chemical and physical data
FormulaC75H126N12O14S2
Molar mass1484.02 g·mol−1

Lipo-oxytocin-1 (LOT-1) is a synthetic peptide and derivative of oxytocin that acts as an agonist of the oxytocin receptor.[1] The lipidation strategy was applied to oxytocin to create a new peptide with improved pharmacokinetics.[1] LOT-1 consists of oxytocin conjugated with two palmitoyl groups.[1] After adjusting for molecular weight (LOT-1 is ~1.5x the weight of oxytocin), oxytocin and LOT-1 are equipotent.[1] In addition, LOT-1 appears to have a significantly longer duration of effect relative to that of oxytocin.[1] It has yet to be determined whether LOT-1 possesses improved blood-brain-barrier permeability relative to oxytocin.[1]

See also

  • Carbetocin
  • Demoxytocin
  • Merotocin
  • Palmitoylation

References

  1. ^ a b c d e f Mizuno A, Cherepanov SM, Kikuchi Y, Fakhrul AA, Akther S, Deguchi K, Yoshihara T, Ishihara K, Shuto S, Higashida H (2015). "Lipo-oxytocin-1, a Novel Oxytocin Analog Conjugated with Two Palmitoyl Groups, Has Long-Lasting Effects on Anxiety-Related Behavior and Social Avoidance in CD157 Knockout Mice". Brain Sci. 5 (1): 3–13. doi:10.3390/brainsci5010003. PMC 4390788. PMID 25612002.


  • v
  • t
  • e
Oxytocin and vasopressin receptor modulators
Oxytocin
Vasopressin
V1A
V1B
  • Ligands: TASP-699
V2
Unsorted
  • Antagonists: Balovaptan
  • Ribuvaptan
  • RWJ-339489
  • VMAX-367
  • VMAX-372
  • VMAX-382
  • YM-222546
Others


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e